1,2,3,4-tetrahydroquinoline has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M; Jiang, Q; Wang, J; Wang, X; Yan, J; Zhang, C; Zhang, X; Zhao, D; Zhao, L | 1 |
| Chen, C; He, G; Huang, W; Jiang, Q; Ouyang, L; Peng, C; Wang, T; Wu, F; Xiang, M | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Experimental Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Quinolines; Structure-Activity Relationship | 2020 |
Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Membrane Proteins; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Quinolines; Reactive Oxygen Species; Structure-Activity Relationship; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2014 |